← Evidence library

BIB_367

Varey 2026 Lancet Oncology SLNB meta-analysis — SLNB associated with REDUCED melanoma-specific mortality + REDUCED recurrence (HR 0.86 + HR 0.71); n=40,287; updates TASK04 framing from "staging-only" toward "therapeutic-benefit signal too".

Evidence grade

A

Tier

1 (Lancet Oncolo

Cited by tasks

4, 5, 6, 7, 17, 24

Identifiers

DOI:10.1016/S1470-2045(26

↗ Follow the original source for full context

Full extracted findings & patient-implication analysis: bibliography/BIB_367/findings.md (research corpus). This page is a short context summary — not individualised medical advice.